ImpediMed Limited (IPDQF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 6.24 Million AUD | -20.54% |
| 2023 | 7.85 Million AUD | 2.64% |
| 2022 | 7.65 Million AUD | -11.92% |
| 2021 | 8.69 Million AUD | 52.39% |
| 2020 | 5.7 Million AUD | -16.08% |
| 2019 | 6.79 Million AUD | 17.88% |
| 2018 | 5.76 Million AUD | 3.95% |
| 2017 | 5.54 Million AUD | 4.33% |
| 2016 | 5.31 Million AUD | 72.6% |
| 2015 | 3.08 Million AUD | 115.99% |
| 2014 | 1.42 Million AUD | 12.28% |
| 2013 | 1.27 Million AUD | -44.88% |
| 2012 | 2.3 Million AUD | 8.58% |
| 2011 | 2.12 Million AUD | -20.82% |
| 2010 | 2.68 Million AUD | -11.58% |
| 2009 | 3.03 Million AUD | 36.85% |
| 2008 | 2.21 Million AUD | -7.16% |
| 2007 | 2.38 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 7.6 Million AUD | 0.0% |
| 2024 Q4 | 6.24 Million AUD | 0.0% |
| 2024 FY | 6.24 Million AUD | -20.54% |
| 2024 Q1 | 7.6 Million AUD | -0.68% |
| 2024 Q3 | 6.24 Million AUD | -17.89% |
| 2023 Q1 | 7.5 Million AUD | -1.93% |
| 2023 FY | 7.85 Million AUD | 2.64% |
| 2023 Q2 | 7.5 Million AUD | 0.0% |
| 2023 Q4 | 7.65 Million AUD | -2.57% |
| 2023 Q3 | 7.85 Million AUD | 4.66% |
| 2022 Q1 | 8.57 Million AUD | -1.3% |
| 2022 FY | 7.65 Million AUD | -11.92% |
| 2022 Q2 | 8.57 Million AUD | 0.0% |
| 2022 Q4 | 7.65 Million AUD | 5.7% |
| 2022 Q3 | 7.24 Million AUD | -15.57% |
| 2021 Q3 | 8.69 Million AUD | 39.41% |
| 2021 FY | 8.69 Million AUD | 52.39% |
| 2021 Q2 | 6.23 Million AUD | 0.0% |
| 2021 Q1 | 6.23 Million AUD | 9.31% |
| 2021 Q4 | 8.69 Million AUD | 0.0% |
| 2020 Q3 | 5.7 Million AUD | -14.5% |
| 2020 FY | 5.7 Million AUD | -16.08% |
| 2020 Q4 | 5.7 Million AUD | 0.0% |
| 2020 Q1 | 6.67 Million AUD | -1.85% |
| 2020 Q2 | 6.67 Million AUD | 0.0% |
| 2019 Q2 | 4.78 Million AUD | 0.0% |
| 2019 Q4 | 6.79 Million AUD | 2.03% |
| 2019 FY | 6.79 Million AUD | 17.88% |
| 2019 Q1 | 4.78 Million AUD | -17.03% |
| 2019 Q3 | 6.66 Million AUD | 39.26% |
| 2018 Q1 | 4.59 Million AUD | -17.24% |
| 2018 FY | 5.76 Million AUD | 3.95% |
| 2018 Q3 | 5.66 Million AUD | 23.38% |
| 2018 Q2 | 4.59 Million AUD | 0.0% |
| 2018 Q4 | 5.76 Million AUD | 1.8% |
| 2017 Q3 | 5.46 Million AUD | 5.11% |
| 2017 Q2 | 5.2 Million AUD | 0.0% |
| 2017 FY | 5.54 Million AUD | 4.33% |
| 2017 Q1 | 5.2 Million AUD | -2.13% |
| 2017 Q4 | 5.54 Million AUD | 1.41% |
| 2016 FY | 5.31 Million AUD | 72.6% |
| 2016 Q4 | 5.31 Million AUD | 2.21% |
| 2016 Q3 | 5.2 Million AUD | 34.25% |
| 2016 Q2 | 3.87 Million AUD | 0.0% |
| 2016 Q1 | 3.87 Million AUD | 25.78% |
| 2015 FY | 3.08 Million AUD | 115.99% |
| 2015 Q4 | 3.08 Million AUD | 3.49% |
| 2015 Q2 | 2.74 Million AUD | 0.0% |
| 2015 Q1 | 2.74 Million AUD | 92.57% |
| 2015 Q3 | 2.97 Million AUD | 8.38% |
| 2014 Q1 | 1.46 Million AUD | 15.04% |
| 2014 Q4 | 1.42 Million AUD | 6.74% |
| 2014 FY | 1.42 Million AUD | 12.28% |
| 2014 Q3 | 1.33 Million AUD | -8.56% |
| 2014 Q2 | 1.46 Million AUD | 0.0% |
| 2013 Q2 | 1.13 Million AUD | 0.0% |
| 2013 Q3 | 1.18 Million AUD | 4.77% |
| 2013 Q4 | 1.27 Million AUD | 7.08% |
| 2013 FY | 1.27 Million AUD | -44.88% |
| 2013 Q1 | 1.13 Million AUD | -50.87% |
| 2012 FY | 2.3 Million AUD | 8.58% |
| 2012 Q4 | 2.3 Million AUD | 0.0% |
| 2011 FY | 2.12 Million AUD | -20.82% |
| 2011 Q4 | 2.12 Million AUD | 0.0% |
| 2010 FY | 2.68 Million AUD | -11.58% |
| 2010 Q4 | 2.68 Million AUD | 0.0% |
| 2009 FY | 3.03 Million AUD | 36.85% |
| 2009 Q4 | 3.03 Million AUD | 0.0% |
| 2008 Q4 | 2.21 Million AUD | 0.0% |
| 2008 FY | 2.21 Million AUD | -7.16% |
| 2007 FY | 2.38 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 2.11 Million USD | -194.759% |
| Össur hf. | 688.8 Million USD | 99.094% |
| QHSLab, Inc. | 2.05 Million USD | -203.493% |
| Wellstar International, Inc. | 55.99 Million USD | 88.85% |
| Össur hf. | 688.8 Million USD | 99.094% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | -111.746% |
| Aurora Spine Corporation | 6.65 Million USD | 6.17% |
| BrainsWay Ltd. | 15.31 Million USD | 59.233% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| AVITA Medical, Inc. | 19.86 Million USD | 68.574% |
| CVR Medical Corp. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 86.382% |
| BioElectronics Corporation | 16.62 Million USD | 62.443% |
| Vivos Inc. | 245 Thousand USD | -2448.122% |
| Kelyniam Global, Inc. | 1.01 Million USD | -516.328% |
| Zecotek Photonics Inc. | 5.86 Million USD | -6.38% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -2165.124% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 61.177% |
| Avitar, Inc. | 11.59 Million USD | 46.151% |
| Nanomix Corporation | 14.81 Million USD | 57.86% |
| Theraclion SA | 13.01 Million EUR | 52.038% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | -21.834% |
| NewCardio, Inc. | 6.01 Million USD | -3.831% |
| Positron Corporation | 2.02 Million USD | -208.144% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -72.403% |
| Lombard Medical, Inc. | 53.79 Million USD | 88.395% |
| ALR Technologies Inc. | 24.5 Million USD | 74.524% |
| Stratec SE | 271.97 Million USD | 97.705% |
| Vycor Medical, Inc. | 4.31 Million USD | -44.588% |
| Heart Tronics, Inc. | 1.09 Million USD | -470.247% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -164.67% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.749% |
| VMS Rehab Systems, Inc. | 201.36 USD | -3100317.163% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -14.027% |
| Ingen Technologies, Inc. | 5.7 Million USD | -9.343% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -154.836% |
| Odyssey Group International, Inc. | 6.61 Million USD | 5.577% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 90.482% |
| IR-Med Inc. | 634 Thousand USD | -884.7% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -13.995% |
| United American Healthcare Corporation | 119 Thousand USD | -5146.218% |
| Polarean Imaging plc | 2.58 Million USD | -141.926% |
| ECGI Holdings, Inc. | 11.94 Million USD | 47.715% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -371.531% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -331.642% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -821.318% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -15.695% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 26.401% |
| SS Innovations International, Inc. | 11.18 Million USD | 44.165% |
| Urologix, Inc. | 12.64 Million USD | 50.625% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -1088.267% |
| Smith & Nephew plc | 4.76 Billion USD | 99.869% |
| NIOX Group Plc | 9.8 Million USD | 36.31% |
| Fuse Medical, Inc. | 15.11 Million USD | 58.683% |
| Broncus Holding Corporation | 10.43 Million USD | 40.156% |
| Brain Scientific Inc. | 7.42 Million USD | 15.935% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 81.532% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -686.192% |